The Nexus Group
The Nexus Group at its Squirrel Hill office in Pittsburgh, Pennsylvania offers Spravato for adults with treatment-resistant depression and those experiencing suicidal ideation. The FDA-approved esketamine nasal spray is administered in office under the supervision of board-certified clinicians.
Treatment begins with a detailed consultation and assessment to review health history, symptoms, and goals and confirm eligibility. Patients then visit twice a week during the initial phase, self-administering the nasal spray in a comfortable clinical setting and remaining for about two hours of observation afterward.
Session frequency is reduced over time based on progress, with regular clinician check-ins to adjust the plan. Spravato works by boosting glutamate receptors and neuroplasticity, often providing relief sooner than traditional antidepressants and helping patients regain hope.
Spravato® (esketamine)
Offered by this practiceUsed for:
Treatment details are based on information published by the clinic, checked in August 2026.
Mon-Fri: 8 AM - 5 PM
Accepts insurance
In-network with Aetna, Blue Cross Blue Shield/Highmark, Cigna, UPMC, and United Healthcare/United Behavioral Health/Optum, including CHIP products. Does not participate in Medicare or Medicaid. Spravato coverage: 'Most major insurance companies cover the cost of Spravato treatment.'
Self-pay rates listed: New Patient Evaluation $485, Follow-up Visits $320. No per-infusion or per-session pricing stated for ketamine or Spravato. Late cancel/no-show fees: $150 for new patient evaluations, $75 for follow-up appointments. Medication refill fee outside appointment: $70. Documentation fee: minimum $100.
Send your details to The Nexus Group and they can reach out to you directly.
Reviews
Is this your clinic?
Get a featured listing to appear at the top of search results and attract more patients.
Get Featured